A detailed history of Louisiana State Employees Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 34,200 shares of VRTX stock, worth $14 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
34,200
Previous 35,100 2.56%
Holding current value
$14 Million
Previous $16.5 Million 3.32%
% of portfolio
0.3%
Previous 0.32%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$460.0 - $505.78 $414,000 - $455,202
-900 Reduced 2.56%
34,200 $15.9 Million
Q2 2024

Jul 24, 2024

SELL
$392.81 - $485.53 $78,562 - $97,106
-200 Reduced 0.57%
35,100 $16.5 Million
Q1 2024

Apr 23, 2024

SELL
$407.69 - $446.08 $326,152 - $356,864
-800 Reduced 2.22%
35,300 $14.8 Million
Q4 2023

Jan 29, 2024

SELL
$343.0 - $410.68 $102,900 - $123,204
-300 Reduced 0.82%
36,100 $14.7 Million
Q3 2023

Oct 17, 2023

BUY
$338.18 - $362.46 $1.49 Million - $1.59 Million
4,400 Added 13.75%
36,400 $12.7 Million
Q2 2023

Jul 18, 2023

BUY
$314.42 - $351.91 $786,050 - $879,775
2,500 Added 8.47%
32,000 $11.3 Million
Q1 2023

Apr 19, 2023

BUY
$283.23 - $323.1 $28,323 - $32,310
100 Added 0.34%
29,500 $9.29 Million
Q4 2022

Jan 24, 2023

SELL
$285.76 - $321.48 $228,608 - $257,184
-800 Reduced 2.65%
29,400 $8.49 Million
Q3 2022

Oct 19, 2022

BUY
$273.83 - $305.53 $82,149 - $91,658
300 Added 1.0%
30,200 $8.74 Million
Q2 2022

Jul 20, 2022

BUY
$234.96 - $292.55 $46,992 - $58,510
200 Added 0.67%
29,900 $8.66 Million
Q1 2022

Apr 22, 2022

BUY
$221.42 - $260.97 $66,426 - $78,291
300 Added 1.02%
29,700 $8.47 Million
Q4 2021

Jan 14, 2022

SELL
$177.01 - $223.45 $17,701 - $22,345
-100 Reduced 0.34%
29,400 $6.46 Million
Q1 2021

Apr 14, 2021

BUY
$207.02 - $241.31 $414,040 - $482,620
2,000 Added 7.27%
29,500 $6.34 Million
Q4 2020

Jan 11, 2021

BUY
$207.01 - $276.09 $2.96 Million - $3.95 Million
14,300 Added 108.33%
27,500 $6.5 Million
Q3 2020

Oct 19, 2020

BUY
$255.65 - $303.1 $536,865 - $636,510
2,100 Added 18.92%
13,200 $3.59 Million
Q2 2020

Jul 13, 2020

BUY
$225.48 - $295.8 $45,096 - $59,160
200 Added 1.83%
11,100 $3.22 Million
Q1 2020

Apr 13, 2020

SELL
$199.77 - $247.81 $259,701 - $322,153
-1,300 Reduced 10.66%
10,900 $2.59 Million
Q4 2019

Jan 17, 2020

SELL
$166.71 - $223.91 $33,342 - $44,782
-200 Reduced 1.61%
12,200 $2.67 Million
Q3 2019

Oct 24, 2019

SELL
$166.23 - $187.09 $66,492 - $74,836
-400 Reduced 3.13%
12,400 $2.1 Million
Q2 2019

Jul 15, 2019

SELL
$164.61 - $190.37 $115,227 - $133,259
-700 Reduced 5.19%
12,800 $2.25 Million
Q1 2019

Apr 15, 2019

BUY
$163.73 - $194.7 $16,372 - $19,470
100 Added 0.75%
13,500 $2.48 Million
Q4 2018

Jan 14, 2019

SELL
$151.91 - $192.21 $243,056 - $307,536
-1,600 Reduced 10.67%
13,400 $2.22 Million
Q2 2018

Jul 18, 2018

SELL
$145.72 - $169.96 $72,860 - $84,980
-500 Reduced 3.23%
15,000 $2.55 Million
Q1 2018

Apr 18, 2018

BUY
$151.6 - $177.13 $30,320 - $35,426
200 Added 1.31%
15,500 $2.53 Million
Q4 2017

Jan 16, 2018

SELL
$137.28 - $155.55 $54,912 - $62,220
-400 Reduced 2.55%
15,300 $2.29 Million
Q3 2017

Oct 16, 2017

BUY
$148.13 - $162.24 $2.33 Million - $2.55 Million
15,700
15,700 $2.39 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.